Stealth BioTherapeutics Announces Departure of Chief Financial Officer
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization...
Source: prnewswire.com